CURRENT AFFAIRS

2023

Please wait while the activity loads.
If this activity does not load, try refreshing your browser. Also, this page requires javascript. Please visit using a browser with javascript enabled.

If loading fails, click here to try again

Question [CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]

What is the name of COVID-19 vaccine developed by Bharat Biotech India Ltd in collaboration with the Indian Council of Medical Research-National Institute of Virology?

A	Coroxin
B	Covaxin
C	Covanin
D	Coronin

Explanation:

Detailed explanation-1: -Developed by Bharat Biotech in collaboration with the Indian Medical Research Council (ICMR) and National Institute of Virology (NIV), COVAXIN™ (BBV152) is India’s first indigenous, whole-virion, inactivated vaccine for the treatment of the highly infectious disease Covid-19.

Detailed explanation-2: -iNCOVACC-Intranasal Vaccine For Covid-19 | Bharat Biotech.

Detailed explanation-3: -in collaboration with the National Institute of Virology (NIV) and ICMR. The effectiveness of Covaxin was found to be 78-81%. Covishield, which is available by code name AZD1222, was developed by the SII, Oxford University, and AstraZeneca.

Detailed explanation-4: -Covaxin™ Vaccine 2023. Bharat Biotech’s Covaxin™ (BBV152) whole virion, inactivated COVID-19 vaccine is based on the Asp614Gly variant. that uses adjuvant Alhydroxiquim-II to boost immune response and longer-lasting immunity.

Detailed explanation-5: -COVID-19 vaccines (tozinameran (BNT162b2) and mRNA-1273 SARS-CoV-2) received FDA emergency use authorized (EUA) to prevent COVID-19 caused by the SARS-CoV-2 virus. This activity reviews the indications, administration, and contraindications for COVID-19 vaccines: tozinameran (BNT162b2) and mRNA-1273 SARS-CoV-2.

There is 1 question to complete.